special family of GTPases with two adjacent GTP-binding domains, each comprising a full set of GTP-binding sites. Homologs appeared to be present in Bacillus subtilis, Haemophilus influenzae, Mycoplasma genitalium, and Mycobacterium leprae (26) . Degenerate PCR primers based on the G-1 and G-3 sites of the first GTPase domain of the C. jejuni GTPase gene allow amplification of a 153-bp fragment from C. jejuni, C. coli, C. lari, and C. upsaliensis. This report describes further analysis of the 153-bp PCR products and development of a reverse hybridization format that allows rapid identification of the four thermotolerant Campylobacter species. The performance of this reverse hybridization test was evaluated by analysis of a large number of Campylobacter reference strains and wellcharacterized clinical isolates from various geographic locations.
MATERIALS AND METHODS
Bacterial strains. Five different panels were analyzed, comprising a total of 320 bacterial strains. The first panel contained 49 reference strains obtained from the BCCM/LMG Culture Collection (Ghent, Belgium). For most strains, the country of origin is given. The panel comprised C. jejuni (n ϭ (8, 22) .
The second panel comprised 56 clinical isolates from The Netherlands (n ϭ 39) and Belgium (n ϭ 17). All isolates of C. jejuni (n ϭ 19), C. coli (n ϭ 35), and C. lari (n ϭ 2) were identified by conventional methods and by whole-cell protein profiling (22) .
Panel 3 comprised a total of 100 Campylobacter strains from Australia, including C. jejuni (n ϭ 78), C. coli (n ϭ 19), and C. lari (n ϭ 3), that were analyzed by Campy-API and conventional biochemical analysis as described earlier (15) . Some isolates also had been analyzed by protein profiling and DNA-DNA dot blot hybridization.
Panel 4 comprised 25 Campylobacter isolates from humans (blood and stool) and hogs and included C. jejuni (n ϭ 3), C. coli (n ϭ 10), C. lari (n ϭ 3), and C. upsaliensis (n ϭ 9) strains. These isolates were obtained from the United States (n ϭ 18), Thailand (n ϭ 3), France (n ϭ 2), and Bangladesh (n ϭ 2). All isolates had been identified earlier by conventional biochemical methods.
Panel 5 contained a total of 90 strains from a reference laboratory in Switzerland, including C. jejuni (n ϭ 60), C. coli (n ϭ 15), C. hyointestinalis (n ϭ 1), C. fetus (n ϭ 6), C. sputorum (n ϭ 1), Helicobacter sp. (n ϭ 5), and Arcobacter butzleri (n ϭ 2). Most of these strains were unusual in either antimicrobial resistance pattern or phenotypic identification (e.g., nalidixic acid resistant or hippurate-negative C. jejuni) and were therefore sent to the reference laboratory. These isolates also had been identified earlier by dot blot DNA hybridization with whole genomic DNA as described earlier (6) , as well as by conventional biochemical methods.
DNA isolation. Bacterial DNA was isolated from cultures of panels 1 and 2 as described earlier (12, 20) . For strains from panels 3, 4, and 5, bacteria were harvested in 2 ml of sterile phosphate-buffered saline, pelleted by centrifugation for 2 min at 12,000 ϫ g, resuspended in 400 l of 10 mM Tris [pH 8.0]-5 mM EDTA-0.1% sodium dodecyl sulfate-0.1-mg/ml proteinase K, and incubated for at least 2 h at 55°C. Proteinase K was inactivated for 10 min at 95°C, and the lysate was clarified by centrifugation for 5 min at 12,000 ϫ g. The supernatant was diluted 1/100 in sterile water and used directly for PCR.
GTP-based PCR primers. The PCR studies were based on PCR primers that have been deduced from the semiconserved GTP-binding G-1 and G-3 amino acid motifs of the putative GTPase gene first found in C. jejuni (24) (GenBank accession no. U63330). Primer target sites also have been sequenced from C. coli, C. lari, and C. upsaliensis. Forward primers GTP-F1 (5Ј biotin-GGiAARCCAA ATGTiGGiAARTC 3Ј) and GTP-F1D (5Ј biotin-GAAAACCAAATGTYGGC AAATC 3Ј) are based on the G-1 GTP-binding site [consensus, G(X) 4 GKS/T; X means any amino acid], and reverse primer GTP-R1 (5Ј biotin-CTYTCATCRA GiCCiCCRCTATC 3Ј) is based on the G-3 GTP-binding site (consensus, DXXG).
PCRs. PCR mixtures (50 l) consisted of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 4.0 mM MgCl 2 , 200 M deoxynucleoside triphosphates, 1.5 U of AmpliTaq Gold DNA polymerase, and 70 pmol of each primer. PCRs comprised 40 cycles of 30 s at 94°C, 45 s at 60°C, and 45 s at 74°C. Prior to cycling, the samples were heated at 94°C for 9 min to activate the Taq DNA polymerase. Approximately 10 ng of bacterial DNA, as estimated by gel electrophoresis, or 2 l of a 1/100-diluted bacterial lysate (see above) was used as the template for amplification.
Analysis of amplified fragments. PCR products were separated and visualized on 2% agarose gels. PCR products were directly sequenced by using cycle sequencing (Amersham) and assayed on an ALF-Express electrophoresis unit (Pharmacia Biotech). Sequences were analyzed by the PCGene software (Intelligenetics Inc.) and the Clustal alignment software. Phylogenetic distances were calculated by pairwise sequence comparisons by the Windows Easy Tree software using the Jukes and Cantor parameters (the software is freely available [21a] ). Phylogenetic relationships were further analyzed by the neighbor-joining method. The program TREECON (24) was used to create a graphic output.
Reverse hybridization LiPA. Based on the sequence alignments, species-specific probes for C. jejuni, C. coli, C. lari, and C. upsaliensis were selected. Probes Cj41 (CTTTTTAATAGAATGGCAAGACAAAG), Cj 413 (CTTTTTAATAG AATGGCAAGACAA), and Cj443 (TTCATATTCATTCAAAAAAAGCCAT GCTT) are specific for C. jejuni. Probes Cc453 (ATCAAGTTTATTTAACAG AATGGCAAG) and Cc473 (CCAATAAAACAGAATGGTTTATAAATTC) are specific for C. coli. Probes Cl492-2 (GACTTGCAAGAAARCGYAT), Cl493 (TAGACTTGCAAAAAAACGCAT), Cl50-2 (ACATAAGYGGRACYACAA G), and Cl501-1 (ATATTAGCGGCACAACAAG) hybridize to C. lari amplimers. Probes Cu562 (TAATCGCATAGCAAGGCAA) and Cu582 (TATCA ATGGTAAAGAAGCCTT) specifically recognize C. upsaliensis. (Y ϭ C or T; S ϭ G or C; R ϭ G or A; i ϭ inosine.) Probe length and composition were adapted to allow specific hybridization of all probes under a single hybridization condition. Methods used to prepare the line probe assay (LiPA) strips and perform the reverse hybridization assays are identical to those described for differentiating H. pylori genotypes (25) . The reverse hybridization was performed in an AutoLiPA (Innogenetics), and results were interpreted visually.
Alternative genotyping. An alternative genotyping method for C. jejuni, C. coli, and C. upsaliensis was recently described by Jackson et al. (16) and is based on restriction fragment length polymorphism (RFLP) analysis of 256-bp amplimers of an uncharacterized gene of C. jejuni by AluI, DdeI, and DraI. The analysis was performed as previously described (16) .
RESULTS
Recently, a novel GTPase-encoding gene of C. jejuni was identified (26) . This gene contains two complete GTPase domains, each comprising a set of semiconserved GTP-binding motifs, in contrast to typical GTPases, which only contain a single GTP-binding domain. Homologs of the C. jejuni GTPase, also containing two separate GTPase domains, had been found earlier in B. subtilis, H. influenzae, M. genitalium, and M. leprae (26) . In addition, the most recent database search (August 1998) revealed that Helicobacter pylori, Synechocystis sp., Buchnera aphidicola, Borrelia burgdorferi, Escherichia coli, Aquifex aeolicus, Treponema pallidum, and Mycobacterium tuberculosis also contain homologs.
Based on the semiconserved GTP-binding sites, PCR primers were selected that permit general amplification of a 153-bp fragment from C. jejuni, C. coli, C. lari, and C. upsaliensis. Degenerate primers were used to amplify fragments from the four thermotolerant species, since these show limited but consistent species-specific heterogeneity in their G-1 and G-3 GTP-binding site sequences (data not shown). In the present study, we further analyzed the heterogeneity of the GTPasederived sequences flanked by these semiconserved GTP-binding sites. The entire PCR-LiPA system based on the speciesspecific sequence variation was evaluated extensively by analysis of reference and clinical isolates.
Phylogenetic analysis of the 153-bp amplimer. The specificity of the GTPase-based PCR with respect to other Campy- lobacter species and non-Campylobacter bacterial isolates has been described previously (26) . To assess the heterogeneity of the GTPase fragments from various Campylobacter species, 153-bp PCR products amplified from a total of 53 isolates, comprising C. jejuni (n ϭ 11), C. coli (n ϭ 9), C. lari (n ϭ 27), and C. upsaliensis (n ϭ 6), described earlier (26) were directly sequenced ( Fig. 1) , and phylogenetic analysis was performed. C. lari sequences also were obtained from strains that were cultured from mussels and oysters (9, 27) . All sequences remain in frame, and no stop codons were found. The phylogenetic tree shows four distinct clusters, representing C. jejuni, C. coli, C. lari, and C. upsaliensis (Fig. 2) . Intraspecies phylogenetic distances (using Jukes and Cantor parameters) are limited in C. jejuni (0.017 Ϯ 0.011), C. coli (0.038 Ϯ 0.019), and C. upsaliensis (0.011 Ϯ 0.005) but are considerably greater among C. lari strains (0.126 Ϯ 0.154). Development of a LiPA. Based on the apparent sequence diversity among the 153-bp PCR products from C. jejuni, C. coli, C. lari, and C. upsaliensis, species-specific probes were developed. Because of the limited intraspecies heterogeneity, two probes were selected from different parts of the amplified sequence for each species. To permit analysis by a single-step reverse hybridization assay, probes that had the same hybridization characteristics were developed. The outline of the LiPA strip and representative examples are shown in Fig. 3 .
Evaluation of the PCR-LiPA with reference strains (panel 1). To evaluate the performance of the Campylobacter LiPA, five different panels of Campylobacter isolates were tested. All results are summarized in Table 1 .
In panel 1, a total of 49 reference strains from Western Europe were tested by the Campylobacter LiPA. PCR products from each of the strain reacted exclusively with the corresponding probes on the strip. PCR products from C. hyointestinalis, C. helveticus, C. fetus, and C. mucosalis did not show cross-reactivity to any of the probes on the strip (Fig. 3) . No PCR products were obtained from C. concisus, C. sputorum, C. showae, and C. curvus. These findings indicated the utility of the methods based on the use of known reference strains.
Evaluation of the PCR-LiPA with clinical isolates from The Netherlands. Panel 2 comprised 56 clinical isolates, and all strains were unequivocally identified by PCR-LiPA. Results, except in three cases, were in complete agreement with results from whole-cell protein electrophoresis. LiPA analysis of three isolates, identified as C. coli by conventional methods, reproducibly showed hybridization with both the C. jejuni and C. coli probes, suggesting the presence of both species in the culture. To exclude cross-reactivity between the different probes on the LiPA, single colonies were recultured from the original isolates. LiPA analysis of individual colonies resulted in the exclusive identification of either C. jejuni or C. coli. Two C. coli isolates (strains C30-8 and C30-22) showed weaker reactivity with one of the two C. coli-specific probes on the LiPA (probe Cc473). Sequence analysis revealed several point mutations in the target sequence compared to sequences from reference isolates (Fig. 2) . Thus, for panel 2, the PCR-LiPA analysis correctly identified all of the strains.
Evaluation of the PCR-LiPA with Australian isolates. In panel 3, a total of 100 thermotolerant Campylobacter strains from Australia were analyzed by the PCR-LiPA (Table 1 ). The strains had been analyzed earlier by conventional methods, including catalase and oxidase reactions, growth at 42°C, and API-Campy (15) . Isolates were identified as C. jejuni or C. coli if they were resistant to cephalothin and susceptible to nalidixic acid. C. jejuni was distinguished from C. coli on the basis of positive hippurate hydrolysis. Isolates resistant to nalidixic acid and negative for hippurate hydrolysis were presumptively identified as C. lari. PCR-LiPA yielded completely concordant identification results in 95 (95%) of the 100 strains. Two strains were originally identified as C. coli by API-Campy, but PCRLiPA identified them as C. jejuni. Conversely, two other strains were initially identified as C. jejuni, whereas PCR-LIPA classified them as C. coli. Another strain was originally identified as C. coli, but PCR-LiPA yielded C. lari-specific hybridization. These five discrepant strains were retested by conventional methods (15) , as well as by PCR-LiPA, and the results remained the same. Subsequently, the strains were subjected to the independent DNA-based method of Jackson et al. (16) , and the results were in complete agreement with the PCRLiPA results for all five strains. Although the method of Jackson was not described for identification of C. lari, analysis of a number of C. lari reference strains and clinical isolates yielded discrete RFLP patterns. The single strain identified as C. lari by PCR-LiPA but as C. coli by conventional methods yielded an RFLP pattern matching the patterns of the reference C. lari strains but clearly different from the pattern expected for C. coli (data not shown).
Evaluation of the PCR-LiPA with isolates from the United States and other countries. The fourth panel comprised 25 Campylobacter isolates. Most were obtained in the United States, but others originated from several other countries. All C. jejuni, C. coli, and C. lari strains yielded the expected result by PCR-LiPA. However, one of nine C. upsaliensis strains was identified as C. jejuni by PCR-LiPA and was further analyzed by the method of Jackson et al. (16) , but the results were inconclusive. Complex RFLP patterns with multiple restriction fragments were observed that were compatible with the presence of both C. jejuni, C. coli, C. upsaliensis, and/or other Campylobacter species. This culture probably contains a mix- Evaluation of the PCR-LiPA with Swiss isolates. The fifth panel consisted of 90 strains from Switzerland. PCR-LiPA results were in complete agreement with conventional identification results, except for one C. fetus isolate, which was identified as C. coli by PCR-LiPA. This C. fetus strain also was analyzed by the method of Jackson et al. (16) and yielded an RFLP pattern compatible with C. coli. The PCR primers of Jackson et al. had a very low yield, and since these PCR primers were not intended to amplify C. fetus DNA, this finding may indicate that C. coli DNA was present at a low concentration. Since the other five C. fetus strains in this panel were completely negative (as were the four reference C. fetus strains of panel 1), it is most likely that this C. fetus strain was not completely pure and also contained traces of C. coli.
Taken together, of the 167 strains identified as C. jejuni by conventional methods, 165 (99%) also were identified as C.
jejuni by PCR-LiPA. The two discrepant strains also were identified as C. jejuni by the method of Jackson et al. (16) . Similarly, 80 (93%) of the 86 strains originally identified as C. coli were correctly identified by PCR-LiPA. Three isolates contained a mixture of C. jejuni and C. coli. Two strains were identified as C. jejuni and one was identified as C. lari by PCR-LiPA, and these findings were confirmed by the method of Jackson et al. All (100%) of the 17 C. lari strains were correctly identified. Of the 19 C. upsaliensis strains, 18 (95%) were identified accordingly by PCR-LiPA, whereas 1 isolate was identified as C. jejuni, which was not unequivocally identified by the method of Jackson et al. and probably contained a mixture of strains. Of the 31 isolates that were not identified as either C. jejuni, C. coli, C. lari, or C. upsaliensis by conventional methods but represented clinically closely related species, 30 remained negative by PCR-LiPA, whereas 1 was identified as C. coli and possibly contained a mixture of strains. 
DISCUSSION
Conventional methods for identification of Campylobacter spp. are based on specific enzymatic activities, antibiotic susceptibilities, and growth performance (17) . However, these phenotyping methods often provide inadequate or incorrect discrimination and can be difficult to perform and interpret. Recently, alternative methods based on genetic differences have been developed. Discrimination between various Campylobacter species has been demonstrated by species-specific PCR and/or RFLP analysis (7, 10, 16, 19, 21) . However, these methods require multiple PCRs per sample, and digestion with multiple restriction enzymes can yield electrophoresis patterns that are sometimes difficult to interpret and standardize.
This report describes the development of a simple and rapid method to discriminate among four important thermotolerant Campylobacter species, i.e., C. jejuni, C. coli, C. lari, and C. upsaliensis. The method is based on the amplification of a fragment of a gene that encodes a putative GTPase. The nucleotide sequences of GTPases are highly diverse, except for the GTP-binding motifs, which are conserved at the amino acid level in all GTPases (5) . The strategy of our identification method is the use of PCR primers deduced from these relatively conserved sites that allow amplification of a 153-bp fragment from the four thermotolerant Campylobacter species. Limited degeneracy of primers resulted in amplification of a single fragment from these Campylobacter species with apparently equal efficiency. Moreover, the location and spacing of these GTP-binding sites within GTPase genes are highly conserved, yielding PCR products that are uniform in size. That homologs of the GTPase sequences were found in a number of other bacteria suggests that similar genes may be more widely conserved than previously appreciated. The function of such GTPase-encoding genes, comprising two complete GTPase domains, remains unknown.
Sequences encoding the 16S rRNA are virtually identical in C. jejuni, C. coli, and C. lari and therefore are not adequate for species identification (12) . Phylogenetic analysis of the 117-bp intervening sequence between the GTP-binding sites revealed limited but consistent intraspecies sequence variability among C. jejuni, C. coli, and C. upsaliensis. C. lari appears to be the most heterogeneous group, which is consistent with earlier reports of phenotypic and genotypic heterogeneity among strains of this species (9, 18) .
Based on the consistent interspecies nucleotide sequence heterogeneity, highly specific probes were designed for each of the four species studied. The reverse hybridization principle allows hybridization analysis of amplified DNA fragments with multiple probes in a single step (25) . An important requirement of such an assay is the design and selection of probes with highly similar hybridization characteristics. Stringent hybridization resulted in highly specific signals with no detectable cross-reactivity. Two clinical isolates of C. coli from panel 2 showed weaker reactivity to one of the species-specific probes, indicating limited sequence variation, which was confirmed by sequence analysis (Fig. 1) . These findings illustrate the usefulness of using two different probes for each species on this LiPA strip.
The performance of the test was evaluated with a panel of reference strains that were identified to the species level by various methods. Importantly, the PCR-LiPA method does not require extensive DNA purification or the transport of viable strains. Treatment with proteinase K yielded stable bacterial lysates that could be shipped at ambient temperature and were of sufficient quality for performance of the assay. Also, the PCR-LiPA method only requires a single PCR, followed by a single-step reverse hybridization. The entire procedure, starting with cultured bacteria, can easily be completed within a day.
All of the isolates of C. jejuni, C. coli, C. lari, or C. upsaliensis tested could be identified by the LiPA. For only 9 (2.8%) of 320 isolates tested did the LiPA yield results discordant with those of conventional methods. Three of these samples contained C. jejuni as well as C. coli. In contrast to conventional identification methods, the LiPA allows sensitive detection of cultures, and thus infections, with multiple species. Purification of single colonies from several primary cultures resulted in unequivocal detection of only a single Campylobacter species, indicating that initial detection of two species was not due to cross-reactivity of the probes on the strip. In five of the remaining six discrepant cases, the PCR-LiPA results were confirmed by an alternative molecular method, and in one case, the isolate probably contained a mixture of strains. Our findings strongly confirm previous observations (3, 9) that conventional biochemical identification methods, such as hippurate hydrolysis and resistance to cephalothin and nalidixic acid, are not always accurate for identification of Campylobacter species. Taken together, this study indicates that the specificity of the PCR-LiPA method is virtually 100%.
In conclusion, the present study describes a novel tool that allows simple, rapid, and reliable identification of thermotolerant Campylobacter species. Further experiments will focus on the direct application of the PCR system to clinical samples, such as human feces. This would allow rapid detection of infection with thermotolerant Campylobacter species followed by species identification by reverse hybridization.
